Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
861.62
747.66
3,360.75
1,865.22
1,125.33
237.45
182.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
861.62
747.66
3,360.75
1,865.22
1,125.33
237.45
182.32
Raw Material Cost
398.03
396.07
1,364.83
843.23
203.96
93.41
70.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
206.18
185.36
239.71
158.80
83.50
40.70
31.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.89
2.89
3.70
1.93
0.84
0.60
0.44
Selling and Distribution Expenses
118.09
132.49
197.06
79.45
48.87
32.79
18.62
Other Expenses
-11.66
-7.10
-3.91
-6.70
-3.05
-0.64
-0.11
Total Expenditure (Excl Depreciation)
607.59
645.77
1,766.17
1,016.41
306.72
161.13
119.52
Operating Profit (PBDIT) excl Other Income
254
101.89999999999999
1594.6000000000001
848.8
818.6
76.3
62.800000000000004
Other Income
70.99
69.21
118.32
41.21
-10.53
11.03
3.21
Operating Profit (PBDIT)
353.51
217.37
1,539.78
893.85
797.89
93.02
66.01
Interest
1.89
2.89
3.70
1.93
0.84
0.60
0.44
Exceptional Items
38.73
32.39
-89.93
21.33
0.00
-0.14
0.00
Gross Profit (PBDT)
463.59
351.59
1,995.92
1,021.99
921.36
144.04
111.81
Depreciation
42.16
49.44
64.70
17.72
5.37
4.32
3.03
Profit Before Tax
348.19
197.44
1,381.45
895.53
791.67
87.95
62.54
Tax
44.80
17.16
195.99
129.84
112.44
9.53
6.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
302.47
180.58
1,184.92
765.69
679.23
78.42
56.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
302.47
180.58
1,184.92
765.69
679.23
78.42
56.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.44
-0.30
0.54
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
302.91
180.28
1,185.46
765.69
679.23
78.42
56.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,883.64
3,827.25
4,166.23
3,273.64
972.36
293.20
215.10
Earnings per share (EPS)
3.88
2.29
15.14
9.6
8.51
0.98
0.71
Diluted Earnings per share
3.88
2.29
15.14
9.6
8.51
0.98
0.71
Operating Profit Margin (Excl OI)
27.9%
13.21%
40.37%
44.76%
71.36%
32.71%
32.78%
Gross Profit Margin
45.3%
33.02%
43.03%
48.96%
70.83%
38.86%
35.97%
PAT Margin
35.11%
24.15%
35.26%
41.05%
60.36%
33.03%
30.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 15.23% vs -77.75% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 68.00% vs -84.79% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 90.62% vs -89.57% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -34.48% vs -21.62% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Hangzhou Alltest Biotech Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
861.62
0
861.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
861.62
0
861.62
Raw Material Cost
398.03
0
398.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
206.18
0
206.18
Power Cost
0
0
0.00
Manufacturing Expenses
1.89
0
1.89
Selling and Distribution Expenses
118.09
0
118.09
Other Expenses
-11.66
0.00
-11.66
Total Expenditure (Excl Depreciation)
607.59
0
607.59
Operating Profit (PBDIT) excl Other Income
254.03
0.00
254.03
Other Income
70.99
0
70.99
Operating Profit (PBDIT)
353.51
0
353.51
Interest
1.89
0
1.89
Exceptional Items
38.73
0
38.73
Gross Profit (PBDT)
463.59
0
463.59
Depreciation
42.16
0
42.16
Profit Before Tax
348.19
0
348.19
Tax
44.80
0
44.80
Provisions and contingencies
0
0
0.00
Profit After Tax
302.47
0
302.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
302.47
0
302.47
Share in Profit of Associates
0
0
0.00
Minority Interest
0.44
0
0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
302.91
0
302.91
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,883.64
0
3,883.64
Earnings per share (EPS)
3.88
0
3.88
Diluted Earnings per share
3.88
0
3.88
Operating Profit Margin (Excl OI)
27.90%
0%
0.00
27.90%
Gross Profit Margin
45.30%
0%
0.00
45.30%
PAT Margin
35.11%
0%
0.00
35.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 86.16 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 15.23% vs -77.75% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 30.29 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 68.00% vs -84.79% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 28.25 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 90.62% vs -89.57% in Dec 2023
Annual - Interest
Interest 0.19 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -34.48% vs -21.62% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.90%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






